As only a low systemic IFNβ level was detected by ELISA in the tumour‐bearing mice receiving intratumoral administration of immRNA‐RBCEVs, we performed cytokine immunoassay in the tumour lysates to improve the sensitivity in detecting the lowest concentration of cytokines. The gene discussed is IFNB1; the disease is neoplasm.